Cargando…
Novel Chemokine-Based Immunotoxins for Potent and Selective Targeting of Cytomegalovirus Infected Cells
Immunotoxins as antiviral therapeutics are largely unexplored but have promising prospective due to their high selectivity potential and their unparalleled efficiency. One recent example targeted the virus-encoded G protein-coupled receptor US28 as a strategy for specific and efficient treatment of...
Autores principales: | Spiess, Katja, Jeppesen, Mads G., Malmgaard-Clausen, Mikkel, Krzywkowski, Karen, Kledal, Thomas N., Rosenkilde, Mette M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303859/ https://www.ncbi.nlm.nih.gov/pubmed/28251165 http://dx.doi.org/10.1155/2017/4069260 |
Ejemplares similares
-
Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein
por: Krishna, B. A., et al.
Publicado: (2017) -
Molecular Properties and Therapeutic Targeting of the EBV-Encoded Receptor BILF1
por: Knerr, Julius Maximilian, et al.
Publicado: (2021) -
Reply to: How Many SARS-CoV-2 “Viroporins” Are Really Ion Channels?
por: Toft-Bertelsen, Trine L., et al.
Publicado: (2022) -
Publisher Correction: Reply to: How many SARS-CoV-2 “viroporins” are really ion channels?
por: Toft-Bertelsen, Trine L., et al.
Publicado: (2022) -
Selective Boosting of CCR7-Acting Chemokines; Short Peptides Boost Chemokines with Short Basic Tails, Longer Peptides Boost Chemokines with Long Basic Tails
por: Brandum, Emma Probst, et al.
Publicado: (2022)